Douglas Merkel to United States
This is a "connection" page, showing publications Douglas Merkel has written about United States.
Connection Strength
0.028
-
Primary factor in declining breast cancer mortality rates: early detection or adjuvant therapy? Cancer Pract. 2002 Jan-Feb; 10(1):45-7.
Score: 0.022
-
Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trial. J Clin Oncol. 2004 Mar 15; 22(6):1071-7.
Score: 0.006